Log In
Print this Print this

NURR1 receptor agonist

  Manage Alerts
Collapse Summary General Information
Company Karo Pharma AB
DescriptionNuclear receptor subfamily 4 group A member 2 (NR4A2; NURR1) agonist
Molecular Target Nuclear receptor subfamily 4 group A member 2 (NURR1) (NR4A2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today